Literature DB >> 3207600

Epidermal growth factor receptor status of histological sub-types of breast cancer.

J R Sainsbury1, S Nicholson, B Angus, J R Farndon, A J Malcolm, A L Harris.   

Abstract

The histological breakdown of a consecutive series of 264 surgically resected malignant lesions of the breast was studied. Oestrogen and epidermal growth factor receptor status was quantified and presented along with size and lymph node status of the non-ductal lesions. Those non-ductal tumours containing EGF receptors have all recurred within two years of resection. Twenty-one percent of the lobular carcinomas contained EGF receptors compared to 34% of ductal carcinomas. EGF receptor status appeared to be associated with an increased risk of early recurrence and death whatever the histological sub-type of the breast cancer.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3207600      PMCID: PMC2246782          DOI: 10.1038/bjc.1988.240

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  26 in total

1.  Estrogen control of progesterone receptor in human breast cancer. Correlation with nuclear processing of estrogen receptor.

Authors:  K B Horwitz; W L McGuire
Journal:  J Biol Chem       Date:  1978-04-10       Impact factor: 5.157

2.  Oestrogen receptors, sites of metastatic disease and survival in recurrent breast cancer.

Authors:  J F Stewart; R J King; S A Sexton; R R Millis; R D Rubens; J L Hayward
Journal:  Eur J Cancer       Date:  1981-04       Impact factor: 9.162

3.  Close similarity of epidermal growth factor receptor and v-erb-B oncogene protein sequences.

Authors:  J Downward; Y Yarden; E Mayes; G Scrace; N Totty; P Stockwell; A Ullrich; J Schlessinger; M D Waterfield
Journal:  Nature       Date:  1984 Feb 9-15       Impact factor: 49.962

4.  Binding sites for epidermal growth factor in human uterine tissues and leiomyomas.

Authors:  G E Hofmann; C V Rao; G H Barrows; G S Schultz; J S Sanfilippo
Journal:  J Clin Endocrinol Metab       Date:  1984-05       Impact factor: 5.958

5.  Steroid-hormone receptors and survival after first relapse in breast cancer.

Authors:  A Howell; D M Barnes; R N Harland; J Redford; V H Bramwell; M J Wilkinson; R Swindell; D Crowther; R A Sellwood
Journal:  Lancet       Date:  1984-03-17       Impact factor: 79.321

6.  Epidermal growth factor binding by breast tumor biopsies and relationship to estrogen receptor and progestin receptor levels.

Authors:  S L Fitzpatrick; J Brightwell; J L Wittliff; G H Barrows; G S Schultz
Journal:  Cancer Res       Date:  1984-08       Impact factor: 12.701

7.  Characterization of epidermal growth factor receptor and action on human breast cancer cells in culture.

Authors:  S L Fitzpatrick; M P LaChance; G S Schultz
Journal:  Cancer Res       Date:  1984-08       Impact factor: 12.701

8.  Growth hormone binding to cultured human breast cancer cells.

Authors:  L J Murphy; E Vrhovsek; R L Sutherland; L Lazarus
Journal:  J Clin Endocrinol Metab       Date:  1984-01       Impact factor: 5.958

9.  Insulin receptors in human cancer.

Authors:  E A Benson; I M Holdaway
Journal:  Br J Cancer       Date:  1981-12       Impact factor: 7.640

10.  Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years.

Authors:  H J BLOOM; W W RICHARDSON
Journal:  Br J Cancer       Date:  1957-09       Impact factor: 7.640

View more
  16 in total

1.  Distinct tyrosine autophosphorylation sites negatively and positively modulate neu-mediated transformation.

Authors:  D L Dankort; Z Wang; V Blackmore; M F Moran; W J Muller
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

2.  Expression of epidermal growth factor receptor in normal colorectal mucosa, adenoma, and carcinoma.

Authors:  K Koretz; P Schlag; P Möller
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1990

Review 3.  Oncology.

Authors:  J S Malpas
Journal:  Postgrad Med J       Date:  1990-02       Impact factor: 2.401

4.  Epidermal growth factor-like activity and epidermal growth factor-receptors in human primary breast cancer.

Authors:  Z Kahán; M Szücs; M Vecsernyés; S Eckhardt
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

Review 5.  Role of epidermal growth factor receptor in breast cancer.

Authors:  Hiroko Masuda; Dongwei Zhang; Chandra Bartholomeusz; Hiroyoshi Doihara; Gabriel N Hortobagyi; Naoto T Ueno
Journal:  Breast Cancer Res Treat       Date:  2012-10-17       Impact factor: 4.872

6.  Epidermal growth factor receptor in breast cancer: correlation of quantitative immunocytochemical assays to prognostic factors.

Authors:  C Charpin; B Devictor; P Bonnier; L Andrac; M N Lavaut; C Allasia; L Piana
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

7.  Erlotinib treatment in pretreated patients with non-small cell lung cancer: A Phase II study.

Authors:  G P Stathopoulos; D Trafalis; J Dimitroulis; A Athanasiou; J Koutantos; A Anagnostopoulos
Journal:  Oncol Lett       Date:  2010-03-01       Impact factor: 2.967

Review 8.  Human breast cancer cell line xenografts as models of breast cancer. The immunobiologies of recipient mice and the characteristics of several tumorigenic cell lines.

Authors:  R Clarke
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

9.  Epidermal growth factor receptor (EGFR) expression in operable non-small cell lung carcinoma.

Authors:  Jin-Hee Ahn; Sang-We Kim; Seung-Mo Hong; Cheolwon Suh; Woo Kun Kim; In Chul Lee; Jung-Shin Lee
Journal:  J Korean Med Sci       Date:  2004-08       Impact factor: 2.153

10.  Prognostic value of epidermal growth factor receptor expression in operable non-small cell lung carcinoma.

Authors:  Ekrem Cengiz Seyhan; Sedat Altın; Erdogan Cetinkaya; Sinem Sökücü; Hülya Abalı; Nur Buyukpinarbasili; Neslihan Fener
Journal:  Multidiscip Respir Med       Date:  2010-10-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.